Clinical Trial Update: BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase II clinical trial of BAY59-7939 for atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• BAY59-7939

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Phase 2 | Status: COMPLETED